Cargando…
Cost-utility of stereotactic radiation therapy versus proton beam therapy for inoperable advanced hepatocellular carcinoma
The cost-utility of proton beam therapy was compared to stereotactic body radiation therapy for inoperable advanced hepatocellular carcinoma. A Markov decision-analytic model was performed following time to progression and survival using phase II trial data. Patients transitioned between three healt...
Autores principales: | Leung, Henry W.C., Chan, Agnes L.F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650446/ https://www.ncbi.nlm.nih.gov/pubmed/29088891 http://dx.doi.org/10.18632/oncotarget.17369 |
Ejemplares similares
-
Network meta-analysis of treatment regimens for inoperable advanced hepatocellular carcinoma with portal vein invasion
por: Li, Ming-Feng, et al.
Publicado: (2018) -
Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017) -
Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2015) -
Medically inoperable peripheral lung cancer treated with stereotactic body radiation therapy
por: Kelley, K. D., et al.
Publicado: (2015) -
Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
por: Moore, Assaf, et al.
Publicado: (2017)